Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04738734 · ClinicalTrials.gov registry record · NA
CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts
A NA study, sponsored by Pulse Biosciences.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT04738734 is a NA study that has completed, run by Pulse Biosciences. The registered enrollment target is 150 participants.
The verdict
NCT04738734, a NA study, has completed, sponsored by Pulse Biosciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
This prospective, multicenter, single-blinded, randomized comparison study is designed to compare the safety and effectiveness of the CellFX System to Cryosurgery for the clearance of cutaneous non-genital common warts on all areas of the body excluding the scalp, nose, within the orbital region of the face, plantar or periungual area in healthy adult subjects.
Interventions
- DEVICE CellFX System Device
- DEVICE Cryosurgery Liquid Nitrogen Sprayer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-02-16 |
| Est. Completion | 2022-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04738734
The ClinicalTrials.gov registry entry for NCT04738734 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulse Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CellFX System Device is the first listed.
NCT04738734 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04738734 about?
NCT04738734 is a clinical study titled "CellFX Comparison to Cryosurgery in Cutaneous Non-Genital Common Warts". This prospective, multicenter, single-blinded, randomized comparison study is designed to compare the safety and effectiveness of the CellFX System to Cryosurgery for the clearance of cutaneous non-genital common warts on all areas of the body excluding the scalp, nose, within the orbital region of ...
What is the current status of trial NCT04738734?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2021-02-16. Estimated completion is 2022-09-25.
What interventions are being tested in trial NCT04738734?
The interventions under investigation include: CellFX System Device (DEVICE), Cryosurgery Liquid Nitrogen Sprayer (DEVICE).
Who is sponsoring clinical trial NCT04738734?
This trial is sponsored by Pulse Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.